Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of swedish patients with melanoma: A case-control analysis

Cancer Journal

Volumn 13, Issue 4, 2007, Pages 233-237

  Zhang, Hong ^a,b   Sun, Xiao Feng ^a   Synnerstad, Ingrid ^a   Rosdahl, Inger ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF SKÖVDE   (Sweden)

Author keywords

FAS; FASL; Melanoma; Pigment phenotype; Polymorphisms; Progression; Tumor onset

Indexed keywords

GENOMIC DNA; PIGMENT; FAS ANTIGEN; FAS LIGAND;

ADULT; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; CANCER GROWTH; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA EXTRACTION; DNA ISOLATION; DNA POLYMORPHISM; EYE COLOR; FAS 1377 GENE; FAS 670 GENE; FASL 844 GENE; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HAIR COLOR; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MONONUCLEAR CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SKIN; SUN EXPOSURE; SWEDEN; TUMOR GROWTH; TUMOR LOCALIZATION; DISEASE COURSE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SKIN TUMOR; SUNLIGHT;

ADULT; ANTIGENS, CD95; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FAS LIGAND PROTEIN; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; SKIN NEOPLASMS; SUNLIGHT; SWEDEN;

EID: 35748938818     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e318046f214     Document Type: Article

References (20)

1. Rees J. Plenty new under the sun. J Invest Dermatol. 2006;126:1691-1692.
2. Waring P, Müllbacher A. Cell death induced by the Fas/Fas ligand pathway and its role in pathology. Immunol Cell Biol. 1999;77:312-317.
3. Owen-Schaub L, Chan H, Cusack JC, et al. Fas and Fas ligand interactions in malignant disease. Int J Oncol. 2002;17:5-12.
4. Ouhtit A, Gorny A, Muller HK, et al. Loss of Fas-ligand expression in mouse keratinocytes during UV carcinogenesis. Am J Pathol. 2000;157: 1975-1981.
5. Hill LL, Ouhtit A, Loughlin SM, et al. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science. 1999;285:898-900.
6. Reichmann E. The biological role of the Fas/FasL system during tumor formation and progression. Semin Cancer Biol. 2002;12:309-315.
7. Lai HC, Sytwu HK, Sun CA, et al. Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis. Int J Cancer. 2003;103:221-225.
8. Kayagaki N, Yamaguchi N, Nagao F, et al. Polymorphism of murine Fas ligand that affects the biological activity. Proc Natl Acad Sci U S A. 1997;94:3914-3919.
9. Stierner U, Augustsson A, Rosdahl I, et al. Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure: a case-control study. Melanoma Res. 1991;1:367-375.
10. Sun T, Zhou Y, Li H, et al. FASL-844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J Exp Med. 2005;202:967-974.
11. Ioachim HL, Decuseara R, Giancotti F, et al. FAS and FAS-L expression by tumor cells and lymphocytes in breast carcinomas and their lymph node metastases. Pathol Res Pract. 2005;200:743-751.
12. Kurooka M, Nuovo GJ, Caligiuri MA, et al. Cellular localization and function of Fas ligand (CD95L) in tumors. Cancer Res. 2002;62:1261-1265.
13. Lee SH, Shin MS, Lee HS, et al. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Hum Pathol. 2001;32: 250-256.
14. Munakata S, Watanabe O, Ohashi K, et al. Expression of Fas ligand and bcl-2 in cervical carcinoma and their prognostic significance. Am J Clin Pathol. 2005;123:879-885.
15. O'Brien DI, Nally K, Kelly RG, et al. Targeting the Fas/Fas ligand pathway in cancer. Expert Opin Ther Targets. 2005;9:1031-1044.
16. Reed J, Hakam A, Nicosia SV, et al. Significance of Fas receptor protein expression in epithelial ovarian cancer. Hum Pathol. 2006;36:971-976.
17. Xu T, Sun BC, Li Q, et al. Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells. World J Gastroenterol. 2005;11:3915-3919.
18. Zhang X, Miao X, Sun T, et al. Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J Med Genet. 2005;42:479-484.
19. Lai HC, Lin WY, Lin YW, et al. Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: an analysis of haplotype and gene-gene interaction. Gynecol Oncol. 2005;99:113-118.
20. Bivik CA, Larsson PK, Kagedal KM, et al. UVA/B-induced apoptosis in human melanocytes involves translocation of cathepsins and Bcl-2 family members. J Invest Dermatol. 2006;126:1119-1127.